DMRA Damora Therapeutics, Inc.: institutional ownership and insider trading
101 funds reported holding $1.73B of Damora Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $218M, with 48 new positions and 13 funds selling out; over the last 12 months insiders bought $253K and sold $30.7K on the open market.
Famous investors holding DMRA
- Andreas Halvorsen (Viking Global Investors): $60.1M, 0.2% of the portfolio
- Ken Griffin (Citadel Advisors): $4.33M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $237K, 0.0% of the portfolio
Largest institutional holders of DMRA
- FMR LLC — $240M
- Fairmount Funds Management LLC — $227M
- Avoro Capital Advisors LLC — $98.4M
- VR Adviser, LLC — $93.7M
- BlackRock, Inc. (BLK) — $82.2M
- FCPM III SERVICES B.V. — $63.5M
- RA CAPITAL MANAGEMENT, L.P. — $62.4M
- JANUS HENDERSON GROUP PLC (JHG) — $61.4M
- VIKING GLOBAL INVESTORS LP — $60.1M
- Jupiter Topco LLC — $59.3M
Recent DMRA insider trades
- Sep 25, 2026: Jarrett Jennifer bought 12,500 shares ($253K)
- Jul 6, 2026: Winslow Garrett sold 245 shares ($7.35K)
- Jan 2, 2026: Firmani Lori sold 135 shares ($2.89K)
- Jan 2, 2026: Winslow Garrett sold 255 shares ($5.45K)
5%+ owners
- Avoro Capital Advisors LLC: 6.3% (Schedule 13G, filed May 15, 2026)
- BlackRock, Inc.: 5.1% (Schedule 13G, filed Jul 28, 2026)